| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2026 | 26 May 2026 |
| Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial Results of the Company for the half year and financial year ended March 31 2026 and to discuss the matter of recommendation of a final dividend if any on equity shares of the Company for the financial year ended March 31 2026 subject to approval of the shareholders of the Company. Outcome of the meeting of the Board of Directors held on May 30, 2026: Approval of Audited Financial Results for Half Year & FY 2026; recommendation of dividend @ 5%, i.e.; Rs.0.50- per equity share of face value of Rs.10/- each. (As per BSE announcement dated on : 30.05.2026) | ||
| Board Meeting | 4 Nov 2025 | 24 Oct 2025 |
| Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 ,inter alia, to consider and approve the Unaudited Financial Results for the Half year (H1) ended September 30, 2025, of the financial year 2025-26. Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve the Unaudited Financial Results for the Half year (H1) ended September 30, 2025, of the financial year 2025-26. (As Per BSE Announcement Dated on: 30.10.2025) Disclosure under Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (SEBI Listing Regulations) - Outcome of the meeting of the Board of Directors held on November 04, 2025 and Approved Statement of Deviation(s) and variation(s) under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. (As Per Bse Announcement dated on 04/11/2025) | ||
| Board Meeting | 8 Jul 2025 | 8 Jul 2025 |
| The Board of Directors at its meeting held today inter-alia has considered and approved 1. Appointment of Ms. Mehak Gupta (FCS 10703, COP No. 15013), Practicing Company Secretary, Peer Review Certificate No. 1643/2022, as Secretarial Auditors of the Company, for one term of 05 (five) 2. Regularization of Mr. Vasanth Kumar (DIN: 03570216) as an Independent Director 3. Regularization of Ms. Sapna Parmar (DIN: 10198855) as Director 4. Annual Report for the financial year 2024-25, including Boards Report and Management Discussion & Analysis, for FY25; 5. Convening 08th Annual General Meeting (AGM) on Thursday, August 14, 2025 at 01:00 p.m. (IST 6. Fixing of Friday, August 08, 2025, as the Cut-Off Date to ascertain the names of members who will be entitled to attend and vote in e-voting at the 08th AGM. 7.Appointment of Mr. Saurabh Talwar (COP No. 13338), practicing company secretary, as the Scrutinizer. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
